Forte Biosciences, Inc. — Director's Dealing 2017

Apr 12, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Tocagen Inc (TOCA)
CIK: 0001419041
Period of Report: 2017-04-12

Reporting Person: FOLETTA MARK G (EVP & Chief Financial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$15.12	2027-03-05	Common Stock (69636)		Direct

Footnotes

F1: 1/4th of the shares vest one year after 2/27/2017; 1/48th of the shares vest monthly thereafter over the next 3 years.